Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Albumin for Ascites in Hepatic Cirrhosis
NCT04701697Phase 1Completed
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2020
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of recombinant human albumin in ascites (4 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Safety and tolerance. Started Mar 2020; status: completed.
02
Drugs
recombinant human albumin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT04701697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04701697.